Yousif Capital Management LLC Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

Yousif Capital Management LLC lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,554 shares of the company’s stock after selling 790 shares during the quarter. Yousif Capital Management LLC’s holdings in HCA Healthcare were worth $7,108,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Chung Wu Investment Group LLC purchased a new position in HCA Healthcare during the second quarter valued at $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. Saudi Central Bank purchased a new position in HCA Healthcare in the 1st quarter valued at $26,000. Finally, WPG Advisers LLC purchased a new position in HCA Healthcare in the 1st quarter valued at $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $418.34 on Wednesday. The company’s 50 day simple moving average is $407.16 and its 200-day simple moving average is $376.85. The company has a market capitalization of $97.89 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 1.29 and a beta of 1.40. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the company earned $5.50 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. KeyCorp raised their price target on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. The Goldman Sachs Group initiated coverage on HCA Healthcare in a research report on Tuesday. They set a “buy” rating and a $470.00 price objective on the stock. Truist Financial set a $460.00 price objective on HCA Healthcare in a research report on Tuesday. Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a report on Thursday, September 18th. Finally, Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $431.07.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.